Digoxin associates with mortality in ESRD
- PMID: 20576808
- PMCID: PMC3013530
- DOI: 10.1681/ASN.2009101047
Digoxin associates with mortality in ESRD
Abstract
The safety of prescribing digoxin in ESRD is unknown. Hypokalemia, which frequently occurs among dialysis patients, may enhance the toxicity of digoxin. Here, we analyzed the association between digoxin prescription and survival in a retrospective cohort using covariate- and propensity score-adjusted Cox models to minimize the potential for confounding by indication. Among 120,864 incident hemodialysis patients, digoxin use associated with a 28% increased risk for death (hazard ratio [HR] 1.28; 95% confidence interval 1.25 to 1.31). Increasing serum digoxin level was also significantly associated with mortality (HR 1.19 per ng/ml increase; 95% confidence interval 1.05 to 1.35). This increased mortality risk with level was most pronounced in patients with lower predialysis serum potassium (K) levels (HR 2.53 [P = 0.01] for K <4.3 mEq/L versus HR 0.86 [P = 0.35] for K >4.6 mEq/L). In conclusion, digoxin use among patients who are on hemodialysis associates with increased mortality, especially among those with low predialysis K concentrations.
Figures
Comment in
-
Digitalis and hemodialysis is a bad combination.J Am Soc Nephrol. 2010 Sep;21(9):1418-20. doi: 10.1681/ASN.2010070775. Epub 2010 Aug 12. J Am Soc Nephrol. 2010. PMID: 20705712 No abstract available.
Similar articles
-
Dialysate Potassium, Serum Potassium, Mortality, and Arrhythmia Events in Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study (DOPPS).Am J Kidney Dis. 2017 Feb;69(2):266-277. doi: 10.1053/j.ajkd.2016.09.015. Epub 2016 Nov 17. Am J Kidney Dis. 2017. PMID: 27866964 Free PMC article.
-
Postdialysis Hypokalemia and All-Cause Mortality in Patients Undergoing Maintenance Hemodialysis.Clin J Am Soc Nephrol. 2019 Jun 7;14(6):873-881. doi: 10.2215/CJN.07950718. Epub 2019 May 2. Clin J Am Soc Nephrol. 2019. PMID: 31048327 Free PMC article.
-
Prognostic utility of serum potassium in chronic digoxin toxicity: a case-control study.Am J Cardiovasc Drugs. 2011 Jun 1;11(3):173-8. doi: 10.2165/11590340-000000000-00000. Am J Cardiovasc Drugs. 2011. PMID: 21619380 Free PMC article.
-
A perspective on re-evaluating digoxin's role in the current management of patients with chronic systolic heart failure: targeting serum concentration to reduce hospitalization and improve safety profile.Eur J Heart Fail. 2014 May;16(5):483-93. doi: 10.1002/ejhf.64. Epub 2014 Feb 23. Eur J Heart Fail. 2014. PMID: 24574198 Review.
-
Digoxin remains useful in the management of chronic heart failure.Med Clin North Am. 2003 Mar;87(2):317-37. doi: 10.1016/s0025-7125(02)00172-4. Med Clin North Am. 2003. PMID: 12693728 Review.
Cited by
-
Management of Chronic Heart Failure in Dialysis Patients: A Challenging but Rewarding Path.Rev Cardiovasc Med. 2024 Jun 25;25(6):232. doi: 10.31083/j.rcm2506232. eCollection 2024 Jun. Rev Cardiovasc Med. 2024. PMID: 39076321 Free PMC article. Review.
-
Management of patients with heart failure and chronic kidney disease.Heart Fail Rev. 2024 Sep;29(5):989-1023. doi: 10.1007/s10741-024-10415-9. Epub 2024 Jul 29. Heart Fail Rev. 2024. PMID: 39073666 Review.
-
2023 Consensus of Taiwan Society of Cardiology on the Pharmacological Treatment of Chronic Heart Failure.Acta Cardiol Sin. 2023 May;39(3):361-390. doi: 10.6515/ACS.202305_39(3).20230301A. Acta Cardiol Sin. 2023. PMID: 37229331 Free PMC article.
-
Association between the risk of heart failure hospitalization and end-stage renal disease with digoxin usage in patients with cardiorenal syndrome: A population-based study.Front Public Health. 2023 Jan 17;10:1074017. doi: 10.3389/fpubh.2022.1074017. eCollection 2022. Front Public Health. 2023. PMID: 36733284 Free PMC article.
-
The effect of digoxin on renal function in patients with heart failure.BMC Nephrol. 2021 Oct 26;22(1):349. doi: 10.1186/s12882-021-02562-0. BMC Nephrol. 2021. PMID: 34702219 Free PMC article.
References
-
- The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group. N Engl J Med 336: 525–533, 1997 - PubMed
-
- K/DOQI clinical practice guidelines on cardiovascular disease in dialysis patients: Overview of the epidemiology of cardiovascular disease. Am J Kidney Dis 45: 8–9, 2005 - PubMed
-
- Haji SA, Movahed A: Update on digoxin therapy in congestive heart failure. Am Fam Physician 62: 409–416, 2000 - PubMed
-
- Olshansky B, Rosenfeld LE, Warner AL, Solomon AJ, O'Neill G, Sharma A, Platia E, Feld GK, Akiyama T, Brodsky MA, Greene HL: The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: Approaches to control rate in atrial fibrillation. J Am Coll Cardiol 43: 1201–1208, 2004 - PubMed
-
- Hauptman PJ, Kelly RA: Digitalis. Circulation 99: 1265–1270, 1999 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
